Landauer — Investor Presentation (December 2013)
28 slides from Landauer's investor presentation, Dec 12, 2013
Slide 1: Investor Presentation December 2013
LANDAUER Respect . Innovation Investor Presentation Honesty December 2013 Reliability
Slide 2: Safe Harbor Statement
LANDAUER Safe Harbor Statement ‘Some of the information shared here (including, in particular, the section titled “Fiscal 2013 Outlook") constitutes forward-looking statements that are based on assumptions and involve certain risks and uncertainties. These include the following, without limitation:
Slide 3: Landauer Today
LANDAUER Landauer Today The Global Leader in Radiation Science and Services Business Facts * Based in Glenwood, IL LANDAUER * Approximately 650 employees * Founded in 1954 * Global Platform and Infrastructure * 73,000 annual customers served; 1.8M annual individuals served * 94%+ Customer retention
Slide 4: Radiation Management is Becoming More Complex
LANDAUER Radiation Management is Becoming More Complex New Standards Patient Safety and Tougher State National Public Policy and Federal Regulations Healthcare Consolidation Regulatory Trends * CTPA, MA, RI, TX Evolving Treatments Acquisitions Partnerships Advanced radiation treatment choices and co
Slide 5: Radiation Risk Not Managed Consistently
LANDAUER Radiation Risk Not Managed Consistently Medical Imaging Risks Radiation Oncology Risks Employee Monitoring Risks Incomplete or unknown patient Radiation over/under —dose, Gaps in radiation safety training dose benchmarking & CT protocol imprecise delivery or unintended review exposure due t
Slide 6: Enterprise-Wide Radiation Safety Assessment
LANDAUER Enterprise-Wide Radiation Safety Assessment Core Business Complementary Acquisitions The Only Enterprise-Wide Medical Medical eae Ehvsics Radiation Safety Solution Provider Occupational Imaging : ; Monitoring/Patient Physics/Therapy abe iyy/ Diagnostic ee i Accessories Monitoring Physics Ma
Slide 7: Attractive Niche Business Model — Annuity Focused
LANDAUER Attractive Niche Business Model — Annuity Focused Strong, Stable Core Complementary Targeted Business with Growth Growth Businesses Adjacencies Opportunities Medical Medical [STUTReTay LEeayele Physics Products Army 9 ; 9 ; 90 % Annuity 90% Annuity 100% Service Service Gensumables 10% Equip
Slide 8: Driving Strong Cash Flows
LANDAUER Driving Strong Cash Flows Revenue, Net Income & Cash Flow f 2006, 2007 2008 2009 2010 2011, 2012 mm Revenue jp NetIncome — mg Cash Flow @ Cash Flow Margin Note: “Fiscal 2009Net Income exclides $1.8Mofter-toxiinpact ofcharges **Fiscal 2012 Net income includes §24.1Mpretoxrestcucturing, acqui
Slide 9: Generating Robust Dividend Payments
LANDAUER d Generating Robust Dividend Payments Sep-04 Sep-05 Sep-06 Sep-07 Sep-08 Sep-09 Sep-10 Sep-11 Sep-12Sep-13 e 4 2 a 4 mm Annual Dividend per Share ——Avg Dividend Yield
Slide 10: Executing On Segment Strategies
LANDAUER Executing On Segment Strategies Optimize Core Deliver Sustainable Se ro Maximize Tota and Maximize Total Shareholder Returns
Slide 11: Radiation Measurement Strategic Initiatives
LANDAUER Radiation Measurement Radiation Measurement Strategic Initiatives Optimize Competitive Strategic the Core Growth Expansion O Management/Structure + SBU structure announced FY 2012 + EMEA Management Structure Announced Q4 FY2013 + Globalization/Shared Services Efficiency OIT Platform Enhance
Slide 12: Medical Physics Strategic Initiatives
LANDAUER Medical Physics Strategic Initiatives Optimize Competitive Strategic the Core Growth Expansion (O Management/Structure O Hospital Group (O Business Development - + Refined Management Structure Purchasing Interest + Practice Group Acquisitions Medical FY2012 2011 to C to Curent + Tied to Ent
Slide 13: Medical Products Strategic Initiatives
LANDAUER Medical Products Strategic Initiatives Optimize Competitive Strategic the Core Growth Expansion (O Management/Structure O Revenue Pipeline + Professional / Experienced Expansion Medical Device Management + $8M currently Transition : O New Product — New Segment President Introduction — New S
Slide 14: Q4 FY 2013 Highlights
LANDAUER Optimize the Core Q4 FY 2013 Highlights Competitive Growth Strategic Expansion Radiation Measurement + New Customer Enhancements / Functionality + More than11,000 customerson new online system/ 3,000 on legacy system + EMEA Management Transition Successfully negotiated 2large GPO agreements
Slide 15: Q4 FY 2013 Highlights: MicroStar
LANDAUER Q4 FY 2013 Highli MicroStar 2 “Patient Dose Data Management”
Slide 16: Q4 FY 2013 Highlights: Innovative New Annuity Service Offerings
LANDAUER Q4 FY 2013 Highlights Radiation Measurement Innovative New Annuity Service Offerings RadFacts™ Year to Date Performance Retrieve valuable spiarreyiaacsa SiaBiak saieiban Soe information through Dosimeters Dosimeters [ALARA Performance myLDR’s enhanced dashboard functionality. Here are new t
Slide 17: Q4 FY 2013 Highlights
LANDAUER Q4 FY 2013 Highlights System #1 System #2 Next Pipeline + SAM+ — Proposed Q2 Start + S4M — Proposed Q2 Start + System's Top 21= $29.7M + 12 Hospitals, 9 Cancer Centers, 12 Imaging + 18 Hospitals, 7 Cancer Centers — (not including Systems #1 & #2) Centers + AllModalities- Imaging, Radiation
Slide 18: Q4 FY 2013 Highlights: IZI Medical Products
LANDAUER Q4 FY 2013 Highlights IZI Medical Products Quick Spherz® is a new product that will save you setup time while giving you the same level of accuracy as you have today. Spherz have played an integral role in image- guided procedures performed worldwide. Our proven track record positions IZI a
Slide 19: Financial Overview
LANDAUER Respect Innovation Honesty Reliability Financial Overview
Slide 20: Landauer Financial Overview
LANDAUER Landauer Financial Overview (Sin millions, FYE 9/30) subscription and is recurring in nature ™ Contract with U.S. military to replace its antiquated radiation monitoring system provides opportunities to expand to other global military and first responder markets $152.4 | $150.2 Strategic ex
Slide 21: Revenue and 4Q FY13 Financial Highlights
LANDAUER Revenue a4 2013 m Rad Measurement Adjusted EBITDA Med Physics Fy 2013, Med Products 94 2013 FY 2013 4Q FY13 Financial Highlights Revenue of $39.9 million in the fourth quarter of fiscal 2013. Restructuring and other charges of $1.0 million primarily related to our operations in the EMEA reg
Slide 22: FY 2012 Through FY 2014 Key Drivers
LANDAUER FY 2012 Through FY 2014 Key Drivers = Military Radwatch Revenue: 2012 Actual $4.4M; 2013 Actual $8.1M; 2014 Guidance $2.3M; 2014 Opportunity $12.0M = ITPlatform Enhancement: 3 $4.6M additional expense in 2013 vs. 2012: $2.3M depreciation & $2.3M IT & Customer Service expense + IT expense no
Slide 23: Fiscal Year 2014 Outlook
LANDAUER Fiscal Year 2014 Outlook FY 2014 Outlook vs. FY 2013 Actual ™ Expected Revenue $140 to ™ Risks associated with $160 million military funding for the " Adjusted EBITDA of $46 to Radwatch product in 2013 $49 million ™ Non-cash Stock Based Compensation Expense: = Net IRGBRISOt S1e te S18 $0.6
Slide 24: Dividend Policy
LANDAUER Dividend Policy Recent Dividend Payment ™ Board of Directors declared a regular quarterly cash dividend of $0.55 per share for the fourth quarter of fiscal 2013 — This represents an annual rate of $2.20 per share, consistent with fiscal 2013 levels — For the fourth fiscal quarter, the divid
Slide 25: Appendix
LANDAUER Respect Innovation Honesty Reliability Appendix
Slide 26: New IT Platform Enhancement Expenses
LANDAUER New IT Platform Enhancement Expenses = Depreciation / Steady State / Customer Service / Implementation / Stabilization expenses: — TotalFY 2013 vs. FY 2012 $4.6 million increased expense over prior year + Depreciation, additional $2.4 million > Split between COG's ($1.4 million) and SG&A ($
Slide 27: Landauer I/T Org
LANDAUER Landauer I/T Org: Basis of Support Ww Applications {since 2007) v | Infrastructure ==} {since 2007) LDR IT Evolution: 2006 - 2013 2003 2005 2007 2009 2010 2011 2012 2013 Luxel+ InlightProduct : *COMETProgram iFirst ILS Software «Nagase Landauer i * COMET Phase 2.0} *COMET Phase 3.0, } * Lan
Slide 28: LDR Corporate Evolution
LANDAUER Bill Saxelbynamed Presidentand CEO Acquired I21 Medical Products: Genesis of Medical Products Segment Physics Solutions: Acquired Global ( Genesis of Medical Physics Segment Inbight product technology released Reported FY'06 First launch o Raised annual dividend Revenue of $79M rate from $2